VIRPAX PHARMACEUTICALS INC (VRPX) Stock Analyst Ratings
NASDAQ:VRPX - Nasdaq - US9282512063 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 43% to VRPX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 3.06. This target is 941.17% above the current price.
VRPX was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about VRPX.
In the previous month the buy percentage consensus was at a similar level.
VRPX was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-10-09 | Maxim Group | Downgrade | Buy -> Hold |
| 2024-07-19 | Maxim Group | Upgrade | Hold -> Buy |
| 2024-05-22 | Maxim Group | Downgrade | Buy -> Hold |
| 2022-06-09 | Maxim Group | Initiate | Buy |